Literature DB >> 8304342

Anonymous marker loci within 400 kb of HLA-A generate haplotypes in linkage disequilibrium with the hemochromatosis gene (HFE)

J Yaouanq1, M Perichon, M Chorney, P Pontarotti, A Le Treut, A el Kahloun, V Mauvieux, M Blayau, A M Jouanolle, B Chauvel.   

Abstract

The hemochromatosis gene (HFE) maps to 6p21.3 and is less than 1 cM from the HLA class I genes; however, the precise physical location of the gene has remained elusive and controversial. The unambiguous identification of a crossover event within hemochromatosis families is very difficult; it is particularly hampered by the variability of the phenotypic expression as well as by the sex- and age-related penetrance of the disease. For these practical considerations, traditional linkage analysis could prove of limited value in further refining the extrapolated physical position of HFE. We therefore embarked upon a linkage-disequilibrium analysis of HFE and normal chromosomes from the Brittany population. In the present report, 66 hemochromatosis families yielding 151 hemochromatosis chromosomes and 182 normal chromosomes were RFLP-typed with a battery of probes, including two newly derived polymorphic markers from the 6.7 and HLA-F loci located 150 and 250 kb telomeric to HLA-A, respectively. The results suggest a strong peak of existing linkage disequilibrium focused within the i82-to-6.7 interval (approximately 250 kb). The zone of linkage disequilibrium is flanked by the i97 locus, positioned 30 kb proximal to i82, and the HLA-F gene, found 250 kb distal to HLA-A, markers of which display no significant association with HFE. These data support the possibility that HFE resides within the 400-kb expanse of DNA between i97 and HLA-F. Alternatively, the very tight association of HLA-A3 and allele 1 of the 6.7 locus, both of which are comprised by the major ancestral or founder HFE haplotype in Brittany, supports the possibility that the disease gene may reside immediately telomeric to the 6.7 locus within the linkage-disequilibrium zone. Additionally, hemochromatosis haplotypes possessing HLA-A11 and the low-frequency HLA-F polymorphism (allele 2) are supportive of a separate founder chromosome containing a second, independently arising mutant allele. Overall, the establishment of a likely "hemochromatosis critical region" centromeric boundary and the identification of a linkage-disequilibrium zone both significantly contribute to a reduction in the amount of DNA required to be searched for novel coding sequences constituting the HFE defect.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8304342      PMCID: PMC1918150     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  55 in total

1.  [Letter: Idiopathic hemochromatosis associated with HL-A 3 tissular antigen].

Authors:  M Simon; Y Pawlotsky; M Bourel; R Fauchet; B Genetet
Journal:  Nouv Presse Med       Date:  1975-05-10

2.  Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis.

Authors:  M Simon; M Bourel; R Fauchet; B Genetet
Journal:  Gut       Date:  1976-05       Impact factor: 23.059

3.  Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by family HLA typing.

Authors:  M Simon; M Bourel; B Genetet; R Fauchet
Journal:  N Engl J Med       Date:  1977-11-10       Impact factor: 91.245

4.  Nonuniform recombination within the human beta-globin gene cluster.

Authors:  A Chakravarti; K H Buetow; S E Antonarakis; P G Waber; C D Boehm; H H Kazazian
Journal:  Am J Hum Genet       Date:  1984-11       Impact factor: 11.025

5.  A locus on chromosome 11p with multiple restriction site polymorphisms.

Authors:  D Barker; T Holm; R White
Journal:  Am J Hum Genet       Date:  1984-11       Impact factor: 11.025

6.  Nonrandom association of polymorphic restriction sites in the beta-globin gene cluster.

Authors:  S E Antonarakis; C D Boehm; P J Giardina; H H Kazazian
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

7.  Disease associations with complotypes, supratypes and haplotypes.

Authors:  R L Dawkins; F T Christiansen; P H Kay; M Garlepp; J McCluskey; P N Hollingsworth; P J Zilko
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

8.  An HLA-All association with the hemochromatosis allele?

Authors:  L Le Mignon; M Simon; R Fauchet; G Edan; M Le Reun; P Brissot; B Genetet; M Bourel
Journal:  Clin Genet       Date:  1983-09       Impact factor: 4.438

9.  Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis.

Authors:  C Niederau; R Fischer; A Sonnenberg; W Stremmel; H J Trampisch; G Strohmeyer
Journal:  N Engl J Med       Date:  1985-11-14       Impact factor: 91.245

10.  Transcription analysis, physical mapping, and molecular characterization of a nonclassical human leukocyte antigen class I gene.

Authors:  M J Chorney; I Sawada; G A Gillespie; R Srivastava; J Pan; S M Weissman
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

View more
  22 in total

1.  International workshop on molecular genetics of haemochromatosis, held at Villa Feltrinelli, Gargnano (Bs), Italy, 25 September 1994.

Authors:  M Worwood; P Gasparini; C Camaschella
Journal:  J Med Genet       Date:  1995-04       Impact factor: 6.318

2.  Allelic association under map error and recombinational heterogeneity: a tale of two sites.

Authors:  C Lonjou; A Collins; R S Ajioka; L B Jorde; J P Kushner; N E Morton
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

3.  The age of human mutation: genealogical and linkage disequilibrium analysis of the CLN5 mutation in the Finnish population.

Authors:  T Varilo; M Savukoski; R Norio; P Santavuori; L Peltonen; I Järvelä
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

4.  46,XX, inv(6)(p21.1p23) in a pedigree with hereditary haemochromatosis.

Authors:  C P Venditti; N K Seese; G S Gerhard; A E Ten Elshof; K A Chorney; P N Mowrey; P G Lacey; J H Knoll; M J Chorney
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

5.  Recombinations defining centromeric and telomeric borders for the hereditary haemochromatosis locus.

Authors:  R S Ajioka; P Yu; J R Gruen; C Q Edwards; L M Griffen; J P Kushner
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

6.  A new non-HLA multigene family associated with the PERB11 family within the MHC class I region.

Authors:  L Pichon; A Hampe; T Giffon; G Carn; J Y Legall; V David
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

7.  Haemochromatosis: a gene at last?

Authors:  K J Robson; J D Shearman; A T Merryweather-Clarke; J J Pointon; W M Rosenberg; A P Walker; J S Dooley; A Bomford; R Raha-Chowdhury; M Worwood
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

8.  Haplotype analysis of hemochromatosis: evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes.

Authors:  R S Ajioka; L B Jorde; J R Gruen; P Yu; D Dimitrova; J Barrow; E Radisky; C Q Edwards; L M Griffen; J P Kushner
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

9.  A human homologue to the yeast omnipotent suppressor 45 maps 100 kb centromeric to HLA-A.

Authors:  B Chauvel; I Dorval; P Fergelot; L Pichon; T Giffon; I Gicquel; J Y Le Gall; V David
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

10.  Characterization of a recombinant that locates the hereditary hemochromatosis gene telomeric to HLA-F.

Authors:  L M Calandro; D M Baer; G F Sensabaugh
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.